Camp4 Therapeutics Corp financial data

Symbol
CAMP on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 757% %
Debt-to-equity 31% %
Return On Equity -100% % -375%
Return On Assets -77% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46,881,134 shares
Common Stock, Shares, Outstanding 46,880,185 shares 4560%
Common Stock, Value, Issued $5,000 USD 150%
Weighted Average Number of Shares Outstanding, Basic 27,274,721 shares 4793%
Weighted Average Number of Shares Outstanding, Diluted 27,274,721 shares 4793%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $795,000 USD
Research and Development Expense $39,831,000 USD -3.6%
General and Administrative Expense $17,291,000 USD 21%
Operating Income (Loss) $53,814,000 USD -1%
Nonoperating Income (Expense) $416,000 USD -4625%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $53,398,000 USD -3.7%
Earnings Per Share, Basic 63 USD/shares 98%
Earnings Per Share, Diluted 63 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $75,255,000 USD 2877%
Other Assets, Current $204,000 USD -30%
Assets, Current $77,708,000 USD 1312%
Property, Plant and Equipment, Net $2,895,000 USD
Operating Lease, Right-of-Use Asset $4,078,000 USD -37%
Assets $86,395,000 USD 304%
Accounts Payable, Current $585,000 USD -85%
Employee-related Liabilities, Current $2,050,000 USD 20%
Accrued Liabilities, Current $4,065,000 USD 11%
Contract with Customer, Liability, Current $0 USD
Liabilities, Current $7,903,000 USD -33%
Operating Lease, Liability, Noncurrent $3,046,000 USD -51%
Other Liabilities, Noncurrent $2,000 USD
Liabilities $27,728,000 USD 52%
Retained Earnings (Accumulated Deficit) $251,872,000 USD -27%
Stockholders' Equity Attributable to Parent $58,667,000 USD
Liabilities and Equity $86,395,000 USD 304%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,286,000 USD -28%
Net Cash Provided by (Used in) Financing Activities $151,000 USD 25%
Net Cash Provided by (Used in) Investing Activities $279,000 USD -1760%
Common Stock, Shares Authorized 175,000,000 shares -17%
Common Stock, Shares, Issued 46,880,185 shares 4423%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $14,716,000 USD -30%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76,879,000 USD 1752%
Deferred Tax Assets, Valuation Allowance $64,921,000 USD 31%
Deferred Tax Assets, Gross $66,574,000 USD 29%
Operating Lease, Liability $6,272,000 USD -32%
Payments to Acquire Property, Plant, and Equipment $279,000 USD 1760%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $53,398,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid $6,679,000 USD -34%
Property, Plant and Equipment, Gross $10,460,000 USD
Operating Lease, Liability, Current $3,226,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,980,000 USD -44%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,558,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $407,000 USD -56%
Lessee, Operating Lease, Liability, to be Paid, Year Three $264,000 USD -87%
Deferred Tax Assets, Operating Loss Carryforwards $27,667,000 USD 46%
Preferred Stock, Shares Authorized 25,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $263,000 USD
Operating Lease, Payments $3,454,000 USD 14%
Additional Paid in Capital $310,534,000 USD 686%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $421,000 USD -3.4%
Share-based Payment Arrangement, Expense $3,645,000 USD -38%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares